Compugen Ltd. (CGEN) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for joining us today. Welcome to CompuGent's fourth quarter and full year 2025 Revolve Council's call. At this time, all participants are in listen-only mode. An audio webcast of this call is available in the investor section of CompuGent's website, www.cgen.com. As a reminder, today's call is being recorded. With us from the CompuGent team are Dr. Erana Fil, President and CEO, and David Silberman, Chief Financial Officer. Dr. Michelle Mahler, Chief Medical Officer, will join for the Q&A. Before we begin, we would like to remind you that during this call, the company may make projections or forward-looking statements regarding future events, business outlook, development efforts, and their potential outcome, the company's discovery platform, anticipated progress and plans, results and timelines for our program, including disclosure of clinical data, financial and accounting-related matters, as well as statements regarding our cash position and cash runways. We wish to caution you that such statements reflect only the company's current beliefs, expectations, and assumptions, but actual results, performance, or achievements of the company may differ materially. These statements are subject to known and unknown risks and uncertainties, and we refer to you our SEC filing for more details on these risks, including the company's most recent annual report on Form 28. The company undertakes no obligation to update projections and forward-looking statements in the future. With that, I now turn the call over to Eran. Thank you, Operator. And welcome to everyone joining our call today. On today's call, I would like to highlight some of our key achievements in 2025 and outline our planned strategic priorities for 2026. During 2025, we made progress across our business,...